3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Inhibition, Psychological
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
venetoclax
5
Rituximab
5
Cyclophosphamide
4
Whole-Body Irradiation
3
Magnetic Resonance Spectroscopy
3
Cyclosporine
3
zanubrutinib
2
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Specimen Handling
2
Prednisone
2
Mycophenolic Acid
2
Lenalidomide
2
CT-P10
2
Biopsy
2
treosulfan
1
pomalidomide
1
obinutuzumab
1
ibrutinib
1
Vincristine
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
tazemetostat
×
30 days
×
Clear all
No trials found.